Galnon TFA is a selective, non-peptide agonist specifically targeting the galanin receptors GAL1 and GAL2, demonstrating binding affinities (Kis) of 11.7 and 34.1 uM, respectively. This compound exhibits both anticonvulsant and anxiolytic effects, as supported by references (1) (2).